Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

1,258

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

1,258 results for “neuroblastoma”

Learn how ShareScore rates datasets ↗
CCDI Data Catalog16/100

Neuroblastoma Genome-Wide Association Study

Neuroblastoma is a malignancy of the developing sympathetic nervous system that most commonly affects young children and is often lethal. The etiology of this embryonal cancer is not fully understood. We therefore initiated a genome-wide association study (GWAS) in 2007 focused on neuroblastoma patients identified through the Children's Oncology Group (COG; 238 member institutions). Control patients for this study are children cared for at the Children's Hospital of Philadelphia (CHOP) without a diagnosis or family history of cancer. The study was initially designed to genotype 5,000 neuroblastoma cases and 10,000 controls and is powered to detect common susceptibility variants in Caucasian and African American patients. Whole genome genotyping was performed on multiple versions of Illumina SNP arrays. This version of the study represents the complete set of cases genotyped.

unknownView details →
CCDI Data Catalog16/100

Elucidating Transcription Regulation by Epigenetics in Neuroblastoma

Whole-genome profiles of the epigenetic modification 5-hydroxymethylcytosine (5-hmC) are robust diagnostic biomarkers in adult patients with cancer. We investigated if 5-hmC profiles would serve as novel prognostic markers in neuroblastoma, a clinically heterogeneous pediatric cancer. Because this DNA modification facilitates active gene expression, we hypothesized that 5-hmC profiles would identify transcriptomic networks driving the clinical behavior of neuroblastoma.

unknownView details →
CCDI Hub16/100

TARGET: Neuroblastoma (NBL)

Open the record for dataset details and reuse information.

unknownView details →
CCDI Hub16/100

Clonal evolution during metastatic spread in high-risk neuroblastoma

Open the record for dataset details and reuse information.

unknownView details →
geo16/100

Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma [Bulk RNA-seq]

GEO Series GSE211660. Homo sapiens. 48 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenOct 2023View details →
geo16/100

Human embryonic stem cell-derived neural crest model for neuroblastoma

GEO Series GSE137975. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2021View details →
geo16/100

CaSR modulator in neuroblastoma model [human]

GEO Series GSE73504. Homo sapiens. 15 samples. Type: Expression profiling by array.

openGEO-OpenMar 2016View details →
geo16/100

PHOX2B promotes the occurrence and development of neuroblastoma by activating the MAPK signaling pathway

GEO Series GSE188622. Homo sapiens. 4 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenAug 2022View details →
geo16/100

Genome methylation defines EZH2 inhibitor resistance in neuroblastoma [II]

GEO Series GSE143712. Homo sapiens. 12 samples. Type: Expression profiling by array.

openGEO-OpenAug 2022View details →
geo16/100

Genome methylation defines EZH2 inhibitor resistance in neuroblastoma

GEO Series GSE143714. Homo sapiens. 36 samples. Type: Expression profiling by array.

openGEO-OpenAug 2022View details →
zenodo16/100

Neuroblastoma copper chelation single-cell

<p>To access the data, please send an e-mail to antonietta.salerno@outlook.it specifying a valid reason for your request.</p>

embargoedcc-by-4.0Feb 2024View details →
zenodo16/100

Pre-clinical spheroid models identify BMX as a therapeutic target for metastatic MYCN non-amplified neuroblastoma

<p>The development of targeted therapies has provided new hope for an increasing number of cancer patients affected by previously incurable diseases. The clinical success of this approach, however, is limited by numerous challenges, including a better control of cell plasticity, particularly in refractory and metastatic patients. Here we addressed this question in Neuroblastoma (NB), an aggressive pediatric malignancy, which remains a clinical challenge for high-risk patients. NB originates from neural crest-derived progenitors through defective differentiation programs combined with oncogenic activity due to genetic and epigenetic alterations. In order to identify critical genes responsible for tumor aggressiveness we performed combined chromatin and transcriptome analyses on matched primary xenografts, spheroids and differentiated adherent cultures, which we derived from metastatic non-<em>MYCN</em> amplified (nMNA) NB patients. Our approach identified the kinase <em>BMX</em> among the most differentially regulated genes between patient-derived xenografts and spheroids versus adherent models. We further found that <em>BMX</em> expression is associated with high tumor stage and poor patient survival in multiple NB transcriptomic datasets and critical to maintain the self-renewal and tumorigenic potential of NB spheroids. Moreover, we uncovered a positive correlation between <em>BMX </em>expression and the mesenchymal tumor cell phenotype, which was previously associated with increased chemo-resistance. Finally, we show that BMX inhibitors can readily reverse this cellular state, increase the sensitivity of NB spheroids toward standard of care chemotherapy, and reduce tumor growth in preclinical NB models. Altogether, our study identifies BMX as a novel promising therapeutic target for high-risk patients with relapsed or refractory nMNA NB tumors.</p>

restrictedMay 2023View details →
zenodo16/100

Surgical Planning in Pediatric Neuroblastoma (MICCAI 2023) - Training Dataset

<p>The training dataset for the&nbsp;<a href="https://sppin.grand-challenge.org/">SPPIN</a> challenge. Please do not share this dataset without permision.</p>

restrictedApr 2023View details →
ClinicalTrials.gov16/100

Combination Chemotherapy and Surgery With or Without Radiation Therapy in Treating Patients With Stage 2 or Stage 3 Neuroblastoma

ClinicalTrials.gov study NCT00416676. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov16/100

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

ClinicalTrials.gov study NCT00417053. IPD Sharing: Not stated. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
geo16/100

Study of gene expression changes in TH-MYCN murine neuroblastomas in response to 24hr of panobinostat treatment

GEO Series GSE69869. Mus musculus. 8 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenJul 2015View details →
geo16/100

CaSR modulator in neuroblastoma model

GEO Series GSE73509. Homo sapiens; Mus musculus. 31 samples. Type: Expression profiling by array.

openGEO-OpenMar 2016View details →
geo16/100

ATR inhibition synergizes with alkylating PI polyamide targeting MYCN by suppressing DNA repair in MYCN-amplified neuroblastoma

GEO Series GSE285823. Homo sapiens. 16 samples. Type: Expression profiling by array.

openGEO-OpenJan 2025View details →
geo16/100

Gene expression after treatment with Nutlin 3a (Nut) and Selinexor (Sel) in Neuroblastoma Cells

GEO Series GSE137366. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenDec 2020View details →
geo16/100

Neuroblastoma plasticity during metastatic progression stems from the dynamics of an early sympathetic transcriptomic trajectory

GEO Series GSE237881. Homo sapiens. 3 samples. Type: Expression profiling by high throughput sequencing.

openGEO-OpenSep 2024View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record